Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
podsjeća bolesnike na rizik od fototoksičnosti i scc kože.
reminds patients of the risk of phototoxicity and skin scc.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
podsjeća bolesnike na rizik od fototoksičnosti i scc-a kože.
reminds patients of the risk of phototoxicity and skin scc.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kartica s upozorenjima za bolesnika o fototoksičnosti i scc-u:
patient alert card for phototoxicity and scc:
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
rezultati ispitivanja fototoksičnosti in vitro pokazali su da krizotinib može biti fototoksičan.
the results of an in vitro phototoxicity study demonstrated that crizotinib may have phototoxic potential.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
podsjeća bolesnika kada i kako prijaviti značajne znakove i simptome fototoksičnosti i raka kože.
reminds patients when and how to report relevant signs and symptoms of phototoxicity and skin cancer.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
nema razloga za zabrinutost zbog fototoksičnosti artenimola, jer se ne apsorbira u rasponu od 290-700 nm.
there are no phototoxicity concerns withartenimol, as it does not absorb in the range of 290-700 nm.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
podsjeća zdravstvene radnike na rizik od fototoksičnosti, scc kože te o toksičnosti za jetru povezane uz primjenom vorikonazola.
reminds hcps of the risks of phototoxicity, skin scc and hepatotoxicity reported with voriconazole use.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
bosutinib je procijenjen u ispitivanjima sigurnosne farmakologije, toksičnosti ponovljene doze, genotoksičnosti, reproduktivne toksičnosti i fototoksičnosti.
bosutinib has been evaluated in safety pharmacology, repeated dose toxicity, genotoxicity, reproductive toxicity and photoxicity studies.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
podsjeća zdravstvene radnike na rizik od fototoksičnosti, scc-a kože i toksičnosti za jetru povezanih uz primjenu vorikonazola.
reminds hcps of the risks of phototoxicity, skin scc and hepatotoxicity reported with voriconazole use.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
iclusig je ocijenjen u studijama sigurnosne farmakologije, toksičnosti ponovljenih doza, genotoksičnosti, reproduktivne toksičnosti, fototoksičnosti i kancerogenosti.
iclusig has been evaluated in safety pharmacology, repeat-dose toxicity, genotoxicity, reproductive toxicity, phototoxicity and carcinogenicity studies.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
neklinički podaci ne ukazuju na poseban rizik za ljude na temelju konvencionalnih ispitivanja sigurnosne farmakologije, toksičnosti ponovljenih doza, lokalne tolerancije i fototoksičnosti.
non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, local tolerance, and phototoxicity.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
neklinički podaci ne ukazuju na poseban rizik za ljude na temelju konvencionalnih ispitivanja sigurnosne farmakologije, toksičnosti jednokratne doze, fototoksičnosti, genotoksičnosti i kancerogenosti.
non-clinical data revealed no specific hazard for humans based on conventional studies of safety pharmacology, single dose toxicity, phototoxicity, genotoxicity and carcinogenicity.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
upozorava zdravstvene radnike na rizik od fototoksičnosti, karcinoma skvamoznih stanica kože (scc) kože te o toksičnosti za jetru povezane uz primjenu vorikonazola.
advises hcps on the risks of phototoxicity, skin scc and liver toxicity associated with voriconazole use.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
neklinički podaci ne pokazuju poseban rizik za ljude na temelju konvencionalnih ispitivanja sigurnosne farmakologije, toksičnosti jedne doze, fototoksičnosti, genotoksičnosti, kancerogenog potencijala i juvenilne toksičnosti.
non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, single dose toxicity, phototoxicity, genotoxicity, carcinogenic potential and juvenile toxicity.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kod nilotiniba su provedena ispitivanja farmakološke sigurnosti primjene, toksičnosti ponovljenih doza, genotoksičnosti, reproduktivne toksičnosti, fototoksičnosti i karcinogenosti (na štakorima i miševima).
nilotinib has been evaluated in safety pharmacology, repeated dose toxicity, genotoxicity, reproductive toxicity, phototoxicity and carcinogenicity (rats and mice) studies.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
neklinički podaci ne ukazuju na poseban rizik za ljude na temelju konvencionalnih ispitivanja sigurnosne farmakologije, toksičnosti ponovljenih doza, fototoksičnosti i preosjetljivosti na svjetlost, genotoksičnosti, kancerogenog potencijala, reproduktivne i razvojne toksičnosti.
non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, phototoxicity and photoallergy, genotoxicity, carcinogenic potential, toxicity to reproduction and development.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
dabrafenib je bio fototoksičan u in vitro testu na mišjim fibroblastima 3t3 neutral red uptake (nru) i in vivo pri dozama ≥ 100 mg/kg (> 44 puta kliničke izloženosti temeljeno na cmax) u ispitivanju fototoksičnosti nakon peroralne primjene kod bezdlakih miševa.
dabrafenib was phototoxic in an in vitro mouse fibroblast 3t3 neutral red uptake (nru) assay and in vivo at doses ≥100 mg/kg (>44 times clinical exposure based on cmax) in an oral phototoxicity study in hairless mice.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting